|
|
|
|
|||||
|
|
|
CVS Health Corporation (NYSE:CVS) is included among the 15 Dividend Stocks that Outperform the S&P 500.
On November 13, Wells Fargo analyst Stephen Baxter lowered the firm’s price target on CVS Health Corporation (NYSE:CVS) to $102 from $103 while maintaining an Overweight rating. The analyst noted that Q3 results were generally solid, though the bullish outlook for the Health Care Benefits (HCB) segment in 2025 is somewhat tempered by a steeper Part D medical loss ratio. Wells Fargo’s 2025 EPS estimate was raised, while the 2026 estimate remains unchanged and slightly above CVS’s guidance baseline.
CVS Health Corporation (NYSE:CVS) has faced several challenges in recent years but is gradually adapting to evolving industry demands and implementing initiatives aimed at improving margins and profitability. The company now offers online pharmacy ordering and same-day delivery, allowing patients to skip the line. In addition, it has committed to cost reductions over the coming years and has already made measurable progress.
CVS Health Corporation (NYSE:CVS) continues to expand its primary care operations, highlighted by acquisitions such as Oak Street Health in 2023. It also launched Cordavis, a partnership with biosimilar drugmakers to reduce drug costs and improve accessibility. CVS Health’s diversified and complementary healthcare businesses support its position as a leading company in the sector.
CVS Health Corporation (NYSE:CVS) is a diversified healthcare company operating as both a healthcare provider and a pharmacy benefit manager.
While we acknowledge the potential of CVS as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.
READ NEXT: 15 High Quality Dividend Stocks for Long-Term Investors and 14 Best Up and Coming Dividend Stocks to Buy.
Disclosure: None.
| 1 hour | |
| 7 hours | |
| Dec-01 | |
| Dec-01 | |
| Nov-28 | |
| Nov-28 | |
| Nov-28 | |
| Nov-28 | |
| Nov-26 | |
| Nov-26 | |
| Nov-25 | |
| Nov-25 | |
| Nov-24 | |
| Nov-23 |
Trump Calls Obamacare Insurers Fat and Rich. Investors See Them as Vulnerable.
CVS
The Wall Street Journal
|
| Nov-21 |
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite